DUBLIN--(BUSINESS WIRE)--The "Immunoassay Markets Strategies and Trends. Forecasts by Instrument Type and by Application and by Country. With Multiplex and Point of Care Market Analysis, Executive Guides and including Customized Forecasting and Analysis. 2019 to 2023." report has been added to ResearchAndMarkets.com's offering.
The workhorse of the diagnostic industry is finding new legs. Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile 44 companies, large and small, working in this area.
Scope of the Report
Factors Driving Growth
- Diagnostic Factors
- Changing Technologies Spur Early Instrument Retirement
- Consumer Channels Open Wider
- Immunity Technology Comes of Age
Factors Limiting Growth
- Increased Competition Lowers Price
- Threat from PCR Based Instruments
- Lower Barriers to Entry
- Wellness has a downside
- Immunoassay Instrumentation
- Instrumentation Tenacity
- Declining Cost of Instruments Changes Industry Structure
- Listing of Current Instrument Specifications
- Immunoassay - CRISPR Diagnostics
Key Topics Covered:
1. Introduction and Market Definition
2. Industry Overview
3. Market Trends
4. Immunoassay Recent Developments
5. The Global Market
6. Global Market by Application
7. Immunoassay by Technology
8. Vision of the Future of Immunoassay
Companies Mentioned
- Abbott Diagnostics
- Abcam
- Arlington Scientific
- Awareness Technology
- Beckman Coulter, Inc.
- Becton Dickinson
- BioCartis
- bioMerieux
- Bioneer
- Bio-Rad Laboratories
- Biotek
- Boditech Med, Inc.
- Boster Biological Technology
- Diamedix (Erba Diagnostics)
- Diasorin S.p.A.
- Dynex Technologies
- Fujirebio
- Gold Standard Diagnostics
- Grifols
- Hycor Biomedical
- Immunodiagnostic Systems (IDS)
- Immunodiagnostik AG
- Inova Diagnostics
- JR Biomedical
- Luminex Corp.
- Meso Scale Discovery
- Molecular Devices
- MP Biomedical
- MyCartis
- Ortho Clinical Diagnostics
- PerkinElmer
- Qiagen
- Randox Toxicology
- R&D Systems
- Roche Molecular Diagnostics
- Serametrix
- Siemens Healthineers
- Sigma Aldrich (now Millipore Sigma)
- Tecan
- Thermo Fisher Scientific Inc.
- TOSOH Bioscience
- Wako Diagnostics
For more information about this report visit https://www.researchandmarkets.com/research/hhtmch/global?w=4
